BIOMAT Database Logo BIOMAT Database Logo

Ageing and acetylator phenotype. 1985

B Gachályi, and A Vas, and A Káldor

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

B Gachályi, and A Vas, and A Káldor
Ageing and acetylator phenotype as determined by administration of sulphadimidine.
January 1985, European journal of clinical pharmacology,
B Gachályi, and A Vas, and A Káldor
Endralazine and acetylator phenotype.
May 1983, Lancet (London, England),
B Gachályi, and A Vas, and A Káldor
Isoniazid acetylator phenotype.
February 1989, Indian pediatrics,
B Gachályi, and A Vas, and A Káldor
Acetylator phenotype and lupus erythematosus.
January 1981, Clinical pharmacokinetics,
B Gachályi, and A Vas, and A Káldor
Dihydralazine therapy and acetylator phenotype.
March 1979, International journal of clinical pharmacology and biopharmacy,
B Gachályi, and A Vas, and A Káldor
Acetylator phenotype and congenital malformations.
January 1989, European journal of clinical pharmacology,
B Gachályi, and A Vas, and A Káldor
Acetylator phenotype in psoriasis.
January 1989, Dermatologica,
B Gachályi, and A Vas, and A Káldor
Effects of phenelzine and acetylator phenotype.
December 1981, Neuropharmacology,
B Gachályi, and A Vas, and A Káldor
Procainamide: autoimmune phenomena and acetylator phenotype.
January 1985, The New England journal of medicine,
B Gachályi, and A Vas, and A Káldor
Acetylator phenotype in Behçet's disease.
January 2003, Advances in experimental medicine and biology,
Copied contents to your clipboard!